Mutations and polymorphisms in proapoptotic genes BIM and BAX have been correlated to resistance to treatment in many cancer types, including CML.23, 24. The gene discussed is BCL2L11; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.